Mandate

Vinge advises Carnegie in connection with the acquisition of Erik Penser Bank’s securities business

Vinge has advised Carnegie Investment Bank AB in connection with the acquisition of the business sectors Erik Penser Wealth Management and Erik Penser Corporate Finance as well as the analytical services Penser Access and Penser Future from Erik Penser Bank AB. The consideration for the completed purchase consists of shares in Carnegie and the acquisition is subject to customary conditions from public authorities.

Carnegie Group is currently the Nordic region’s leading financial adviser and asset manager with 800 employees in six countries. Erik Penser Bank offers an extensive portfolio of financial services and was founded through the establishment of Erik Penser Fondkommission in 1994 by Erik Penser.

Vinge’s team primarily consisted of Kristian Ford (responsible partner), Sofie Nordgren, Anna Edström, Henrik Borna and Agaton Lindgren (M&A), Nils Unckel, Anton Sjökvist and Viktoria Wnuk (regulatory), Pär Remnelid (competition), Emelie Svensäter Jerntorp (employment), Lisa Bourghardt (IP), Fredrik Christiansson (banking and finance) and Ulf Nilsson (tax).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025